5
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

6
Role of AI in Theranostics: Towards Routine Personalized Radiopharmaceutical Therapies

von Brosch-Lenz, Julia ; Yousefirizi, Fereshteh ; Zukotynski, Katherine ; et al.

Schlagworte: Physics - Medical Physics
- View full text via Arxiv
Merkliste

7
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

von Schürrle, Seval Beykan ; Eberlein, Uta ; Ansquer, Catherine ; et al.

European Journal of Nuclear Medicine and Molecular Imaging. 51(8):2428-2441
- Zum Volltext (via ReDI)
Merkliste

8
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

von Mansouri, Zahra ; Salimi, Yazdan ; Akhavanallaf, Azadeh ; et al.

European Journal of Nuclear Medicine and Molecular Imaging. 51(6):1516-1529
- Zum Volltext (via ReDI)
Merkliste

9
Additional file 1 of The tumour sink effect on 68Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study

von Atefeh Zamanian ; Étienne Rousseau ; François-Alexandre Buteau ; et al.

Schlagworte: Cell Biology; Immunology; Cancer; Biological Sciences not elsewhere classified; PET/CT; Prostate cancer; Prostate-specific membrane antigen (PSMA); Radiopharmaceutical therapy; Sink effect; PSMA-617; Total lesion fraction (TLF)
- View full text via BASE
Merkliste

10
Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial

von Aaron R. Hansen ; Stephan Probst ; Jean-Mathieu Beauregard ; et al.

Frontiers in Oncology, Vol 14 (2025)

Schlagworte: castration resistant prostate cancer; PSMA; radioligand therapy; PNT2002; dosimetry; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via BASE
Merkliste

11
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours

von Wild, Damian ; Grønbæk, Henning ; Navalkissoor, Shaunak ; et al.

European Journal of Nuclear Medicine and Molecular Imaging. 51(1):183-195
- Zum Volltext (via ReDI)
Merkliste

12

Dieses Ergebnis aus CINAHL kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.

Merkliste

13
Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer

von Jean-Mathieu Beauregard

Cancer Imaging, Vol 22, Iss 1, Pp 1-13 (2022)

Schlagworte: Medical physics. Medical radiology. Nuclear medicine; R895-920; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

14
Role of Artificial Intelligence in Theranostics: Toward Routine Personalized Radiopharmaceutical Therapies

von Brosch-Lenz, Julia ; Yousefirizi, Fereshteh ; Zukotynski, Katherine ; et al.

In PET Clinics October 2021 16(4):627-641
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

15
Impact of the dead-time correction method on quantitative 177Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy

von Alessandro Desy ; Guillaume F. Bouvet ; Nancy Lafrenière ; et al.

EJNMMI Physics, Vol 9, Iss 1, Pp 1-12 (2022)

Schlagworte: Quantitative imaging; Single-photon emission computed tomography; Dead time; Dosimetry; Lutetium-177; Radiopharmaceutical therapy; Medical physics. Medical radiology. Nuclear medicine; R895-920
- View full text via DOI
Merkliste

16
Quantitative SPECT (QSPECT) at high count rates with contemporary SPECT/CT systems

von Alessandro Desy ; Guillaume F. Bouvet ; Étienne Croteau ; et al.

EJNMMI Physics, Vol 8, Iss 1, Pp 1-11 (2021)

Schlagworte: Quantitative SPECT; SPECT/CT; Calibration; Dead time; High count rate; Medical physics. Medical radiology. Nuclear medicine; R895-920
- View full text via DOI
Merkliste

17
Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1

von Laforce, Robert Jr ; Dallaire-Théroux, Caroline ; Racine, Annie M. ; et al.

Journal of Neurology. 269(7):3579-3587
- Zum Volltext (via ReDI)
Merkliste

18
Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers

von Mica T. M. Clarke ; Frédéric St-Onge ; Jean-Mathieu Beauregard ; et al.

Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-8 (2021)

Schlagworte: PET imaging; Glucose metabolism; Presymptomatic; Frontotemporal dementia; Neurosciences. Biological psychiatry. Neuropsychiatry; RC321-571; Neurology. Diseases of the nervous system; RC346-429
- View full text via DOI
Merkliste

19
Increased Prostate Cancer Glucose Metabolism Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8–10 Prostate Cancers Identifies Very High–risk Patients for Early Recurrence and Resistance to Castration

von Lavallée, Etienne ; Bergeron, Michelle ; Buteau, François-Alexandre ; et al.

In European Urology Focus November 2019 5(6):998-1006
- View full text via DOI
Merkliste

20
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial

von Fizazi, Karim ; Herrmann, Ken ; Krause, Bernd J ; et al.

The Lancet Oncology, vol 24, iss 6

Schlagworte: 32 Biomedical and Clinical Sciences (for-2020); 3202 Clinical Sciences (for-2020); 3211 Oncology and Carcinogenesis (for-2020); Cancer (rcdc); Patient Safety (rcdc); Clinical Research (rcdc); Clinical Trials and Supportive Activities (rcdc); Urologic Diseases (rcdc); Prostate Cancer (rcdc); Pain Research (rcdc); 6.1 Pharmaceuticals (hrcs-rac); Cancer (hrcs-hc); 3 Good Health and Well Being (sdg); Male (mesh); Humans (mesh); Aged (mesh); Quality of Life (mesh); Prostatic Neoplasms; Castration-Resistant (mesh); Receptors; Androgen (mesh); Standard of Care (mesh); Androgen Receptor Antagonists (mesh); Pain (mesh); Taxoids (mesh); Antineoplastic Combined Chemotherapy Protocols (mesh)
- View full text via BASE
Merkliste

21
Chemotherapy-mediated upregulation of SSTR2 in NET tumors in mice and in tumor biopsies from lung- and gastroenteropancreatic-NET patients

von Merlin, Marine A. ; Deshaies, Isabelle ; Joubert, Philippe ; et al.

Endocrine Abstracts ; ISSN 1479-6848
- View full text via BASE
Merkliste

22
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)

von Beauregard, Jean-Mathieu ; Rahmim, Arman

European Journal of Nuclear Medicine and Molecular Imaging. 49(2):424-426
- Zum Volltext (via ReDI)
Merkliste

23
GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome

von Meziou, Salma ; Ringuette Goulet, Cassandra ; Hovington, Hélène ; et al.

Prostate Cancer and Prostatic Diseases. 23(3):441-448
- Zum Volltext (via ReDI)
Merkliste

24
Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT

von Alessandro Desy ; Guillaume F. Bouvet ; Andrea Frezza ; et al.

EJNMMI Physics, Vol 7, Iss 1, Pp 1-8 (2020)

Schlagworte: Dead time; Quantitative SPECT; Dosimetry; Radionuclide therapy; 177Lu; Medical physics. Medical radiology. Nuclear medicine; R895-920
- View full text via DOI
Merkliste

25
Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction

von Andrea Frezza ; Corentin Desport ; Carlos Uribe ; et al.

EJNMMI Physics, Vol 7, Iss 1, Pp 1-22 (2020)

Schlagworte: Quantitative SPECT; SPECT/CT; 177Lu; Calibration; Dead time; Medical physics. Medical radiology. Nuclear medicine; R895-920
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag